By Professor Glenda Halliday

Journal articles

Ferrari R; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Brooks William S BS; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Waldö ML; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; Van der Zee J; Deschamps W; Van Langenhove T; Cruts M; Van Broeckhoven C; Cappa SF; Le Ber I; Hannequin D; Golfier V; Vercelletto M; Brice A; Nacmias B; Sorbi S; Bagnoli S; Piaceri I; Nielsen JE; Hjermind LE; Riemenschneider M; Mayhaus M; Ibach B; Gasparoni G; Pichler S; Gu W; Rossor MN; Brooks W; Schofield P, 2014, 'Frontotemporal dementia and its subtypes: A genome-wide association study', The Lancet Neurology, 13, pp. 686 - 699, http://dx.doi.org/10.1016/S1474-4422(14)70065-1

Ferrari R; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Brooks WS; Eld PRS; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernandez I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimon J; Lleo A; Blesa R; Waldoe ML; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung G; Mann DMA; Grafman J; Morris CM; Attems J; Ths TDG; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rubino IRE; Pinessi L; Rogaeva E; St George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; van der Zee J; Deschamps W; Van Langenhove T; Cruts M; Van Broeckhoven C; Cappa SF; Le Ber I; Hannequin D; Golfier V; Vercelletto M; Brice A; Nacmias B; Sorbi S; Bagnoli S; Piaceri I; Nielsen JE; Hjermind LE; Riemenschneider M; Mayhaus M; Ibach B; Gasparoni G; Pichler S; Gu W; Rossor MN; Fox NC; Warren JD; Spillantini MG; Morris HR; Rizzu P; Heutink P; Snowden JS; Rollinson S; Richardson A; Gerhard A; Bruni AC; Maletta R; Frangipane F; Cupidi C; Bernardi L; Anfossi M; Gallo M; Conidi ME; Smirne N; Rademakers R; Baker M; Dickson DW; Graff-Radford NR; Petersen RC; Knopman D; Josephs KA; Boeve BF; Parisi JE; Seeley WW; Miller BL; Karydas AM; Rosen H; van Swieten JC; Dopper EGP; Seelaar H; Pijnenburg YA; Scheltens P; Logroscino G; Capozzo R; Novelli V; Puca AA; Franceschi M; Postiglione A; Milan G; Sorrentino P; Kristiansen M; Chiang HH; Graff C; Pasquier F; Rollin A; Deramecourt V; Lebert F; Kapogiannis D; Ferrucci L; Pickering-Brown S; Hardy J; Momeni P; Singleton AB, 2014, 'Genetic analysis suggests lysosomal and immune system involvement in frontotemporal dementia', JOURNAL OF ALZHEIMERS DISEASE, 41, pp. S25 - S26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000337049200051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Murphy KE; Halliday GM, 2014, 'Glucocerebrosidase deficits in sporadic Parkinson disease', Autophagy, 10, pp. 1350 - 1351, http://dx.doi.org/10.4161/auto.29074

Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D, 2014, 'Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease', Brain, 137, pp. 2493 - 2508, http://dx.doi.org/10.1093/brain/awu193

Lam BYK; Halliday GM; Irish M; Hodges JR; Piguet O, 2014, 'Longitudinal white matter changes in frontotemporal dementia subtypes', Human Brain Mapping, 35, pp. 3547 - 3557, http://dx.doi.org/10.1002/hbm.22420

Kordower JH; Halliday G, 2014, 'Misfolded proteins in Huntington disease fetal grafts: Further evidence of cell-to-cell transfer?', Annals of Neurology, 76, pp. 20 - 21, http://dx.doi.org/10.1002/ana.24205

Chare L; Hodges JR; Leyton CE; McGinley C; Tan RH; Kril JJ; Halliday GM, 2014, 'New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications.', Journal of neurology, neurosurgery, and psychiatry, 85, pp. 865 - 870

Kragh CL; Gysbers AM; Rockenstein E; Murphy K; Halliday GM; Masliah E; Jensen PH, 2014, 'Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy', Neurobiology of Disease, 63, pp. 171 - 183, http://dx.doi.org/10.1016/j.nbd.2013.12.002

Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM, 2014, 'Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease', Brain, 137, pp. 834 - 848, http://dx.doi.org/10.1093/brain/awt367

Shine JM; Halliday GM; Gilat M; Matar E; Bolitho SJ; Carlos M; Naismith SL; Lewis SJG, 2014, 'The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease', Human Brain Mapping, 35, pp. 2206 - 2219, http://dx.doi.org/10.1002/hbm.22321

Berg D; Postuma RB; Bloem B; Chan P; Dubois B; Gasser T; Goetz CG; Halliday GM; Hardy J; Lang AE; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M; Deuschl G, 2014, 'Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease', Movement Disorders, 29, pp. 454 - 462, http://dx.doi.org/10.1002/mds.25844

Gallagher MD; Suh E; Grossman M; Elman L; McCluskey L; Van Swieten JC; Al-Sarraj S; Neumann M; Gelpi E; Ghetti B; Rohrer JD; Halliday G; Van Broeckhoven C; Seilhean D; Shaw PJ; Frosch MP; Alafuzoff I; Antonell A; Bogdanovic N; Brooks W; Cairns NJ; Cooper-Knock J; Cotman C; Cras P; Cruts M; De Deyn PP; Decarli C; Dobson-Stone C; Engelborghs S; Fox N; Galasko D; Gearing M; Gijselinck I; Grafman J; Hartikainen P; Hatanpaa KJ; Highley JR; Hodges J; Hulette C; Ince PG; Jin LW; Kirby J; Kofler J; Kril J; Kwok JBJ; Levey A; Lieberman A; Llado A; Martin JJ; Masliah E; McDermott CJ; McKee A; McLean C; Mead S; Miller CA; Miller J; Munoz DG; Murrell J; Paulson H; Piguet O; Rossor M; Sanchez-Valle R; Sano M; Schneider J; Silbert LC; Spina S; Van Der Zee J; Van Langenhove T; Warren J; Wharton SB; White CL; Woltjer RL; Trojanowski JQ; Lee VMY; Van Deerlin V; Chen-Plotkin AS, 2014, 'TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions', Acta Neuropathologica, 127, pp. 407 - 418, http://dx.doi.org/10.1007/s00401-013-1239-x

Shine JM; O'Callaghan C; Halliday GM; Lewis SJG, 2014, 'Tricks of the mind: Visual hallucinations as disorders of attention', Progress in Neurobiology, 116, pp. 58 - 65, http://dx.doi.org/10.1016/j.pneurobio.2014.01.004

McCann H; Stevens CH; Cartwright H; Halliday GM, 2014, 'α-Synucleinopathy phenotypes', Parkinsonism and Related Disorders, 20, http://dx.doi.org/10.1016/S1353-8020(13)70017-8

Schwartz R; Halliday G; Cordato D; Kril J, 2014, '2.', Journal of Clinical Neuroscience, 21, pp. 2033 - 2033, http://dx.doi.org/10.1016/j.jocn.2014.06.016

Coupland KG; Mellick GD; Silburn PA; Mather K; Armstrong NJ; Sachdev PS; Brodaty H; Huang Y; Halliday GM; Hallupp M; Kim WS; Dobson-Stone C; Kwok JBJ; Kim W; Schofield P, 2014, 'DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E In Vitro', Movement Disorders, 29, pp. 1606 - 1614, http://dx.doi.org/10.1002/mds.25784

Wong JH; Halliday GM; Kim WS, 2014, 'Exploring myelin dysfunction in multiple system atrophy.', Exp Neurobiol, 23, pp. 337 - 344, http://dx.doi.org/10.5607/en.2014.23.4.337

Halliday G, 2014, 'F4‐02‐01: IDENTIFYING THE DYNAMICS OF LEWY BODY FORMATION IN LEWY BODY DISEASES', Alzheimer's & Dementia, 10, http://dx.doi.org/10.1016/j.jalz.2014.04.367

Po K; Leslie FVC; Gracia N; Bartley L; Kwok JBJ; Halliday GM; Hodges JR; Burrell JR, 2014, 'Heritability in frontotemporal dementia: more missing pieces?', Journal of Neurology, 261, pp. 2170 - 2177, http://dx.doi.org/10.1007/s00415-014-7474-9

Coupland K; Kim WS; Halliday G; Dobson‐Stone C; Kwok JBJ, 2014, 'P1‐039: MAPT METHYLATION IN ALZHEIMER'S DISEASE', Alzheimer's & Dementia, 10, http://dx.doi.org/10.1016/j.jalz.2014.05.274

Bleasel JM; Hsiao JHT; Halliday GM; Kim WS, 2013, 'Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins', Journal of Parkinson's Disease, 3, pp. 331 - 339, http://dx.doi.org/10.3233/JPD-130203

Cheshire P; Bertram K; Ling H; O'Sullivan SS; Halliday G; McLean C; Bras J; Foltynie T; Storey E; Williams DR, 2013, 'Influence of single nucleotide polymorphisms in COMT, MAO-A and BDNF genes on dyskinesias and levodopa use in Parkinson's disease', Neurodegenerative Diseases, 13, pp. 24 - 28, http://dx.doi.org/10.1159/000351097

Kemp S; Harding AJ; Halliday GM; Mahant N; Fung VSC, 2013, 'Cortical limb myoclonus in pathologically proven progressive supranuclear palsy', Movement Disorders, 28, pp. 1804 - 1806, http://dx.doi.org/10.1002/mds.25693

Mills JD; Kavanagh T; Kim WS; Chen BJ; Kawahara Y; Halliday GM; Janitz M, 2013, 'Unique Transcriptome Patterns of the White and Grey Matter Corroborate Structural and Functional Heterogeneity in the Human Frontal Lobe', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0078480

Wang JH; Gouda-Vossos A; Dzamko N; Halliday G; Huang Y, 2013, 'DNA extraction from fresh-frozen and formalin-fixed, paraffinembedded human brain tissue', Neuroscience Bulletin, 29, pp. 649 - 654, http://dx.doi.org/10.1007/s12264-013-1379-y

Dang TNT; Dobson-Stone C; Glaros EN; Kim WS; Hallupp M; Bartley L; Piguet O; Hodges JR; Halliday GM; Double KL; Schofield PR; Crouch PJ; Kwok JBJ; Kim W; Schofield P, 2013, 'Endogenous progesterone levels and frontotemporal dementia: Modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model', DMM Disease Models and Mechanisms, 6, pp. 1198 - 1204, http://dx.doi.org/10.1242/dmm.011460

Zhou JX; Zhang HB; Huang Y; He Y; Zheng Y; Anderson JP; Gai WP; Liang ZG; Wang Y; Ren XM; Wang Q; Gong XL; Yang J; Wang X; Halliday G; Wang XM, 2013, 'Tenuigenin attenuates α-synuclein-induced cytotoxicity by down-regulating polo-like kinase 3', CNS Neuroscience and Therapeutics, 19, pp. 688 - 694, http://dx.doi.org/10.1111/cns.12124

Reyes S; Cottam V; Kirik D; Double KL; Halliday GM, 2013, 'Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra', Movement Disorders, 28, pp. 1351 - 1359, http://dx.doi.org/10.1002/mds.25493

Hsiao JHT; Fu YH; Hill AF; Halliday GM; Kim WS, 2013, 'Elevation in Sphingomyelin Synthase Activity Is Associated with Increases in Amyloid-Beta Peptide Generation', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0074016

Dzamko N; Chua G; Ranola M; Rowe DB, 2013, 'Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients', Journal of Parkinson's Disease, 3, pp. 145 - 152, http://dx.doi.org/10.3233/JPD-130174

Dzamko N; Halliday GM, 2013, 'Unlocking the secrets of LRRK2 function with selective kinase inhibitors', Future Neurology, 8, pp. 347 - 357, http://dx.doi.org/10.2217/fnl.13.9

Nalls MA; Duran R; Lopez G; Kurzawa-Akanbi M; McKeith IG; Chinnery PF; Morris CM; Theuns J; Crosiers D; Cras P; Engelborghs S; De Deyn PP; Van Broeckhoven C; Mann DMA; Snowden J; Pickering-Brown S; Halliwell N; Davidson Y; Gibbons L; Harris J; Sheerin UM; Bras J; Hardy J; Clark L; Marder K; Honig LS; Berg D; Maetzler W; Brockmann K; Gasser T; Novellino F; Quattrone A; Annesi G; De Marco EV; Rogaeva E; Masellis M; Black SE; Bilbao JM; Foroud T; Ghetti B; Nichols WC; Pankratz N; Halliday G; Lesage S; Klebe S; Durr A; Duyckaerts C; Brice A; Giasson BI; Trojanowski JQ; Hurtig HI; Tayebi N; Landazabal C; Knight MA; Keller M; Singleton AB; Wolfsberg TG; Sidransky E, 2013, 'A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies', JAMA Neurology, 70, pp. 727 - 735, http://dx.doi.org/10.1001/jamaneurol.2013.1925

Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT, 2013, 'Disease duration and the integrity of the nigrostriatal system in Parkinson's disease', Brain, 136, pp. 2419 - 2431, http://dx.doi.org/10.1093/brain/awt192

Halliday GM, 2013, 'Motor deficits associated with changes in β-amyloid in Parkinson's disease', Journal of Neurology, Neurosurgery and Psychiatry, 84, pp. 475 - 476, http://dx.doi.org/10.1136/jnnp-2012-304177

Ravenscroft TA; Baker MC; Rutherford NJ; Neumann M; Mackenzie IR; Josephs KA; Boeve BF; Petersen R; Halliday GM; Kril J; van Swieten JC; Seeley WW; Dickson DW; Rademakers R, 2013, 'Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS', Neurobiology of Aging, 34, pp. 2235.e11 - 2235.e13, http://dx.doi.org/10.1016/j.neurobiolaging.2013.04.004

Tan RH; Pok K; Wong S; Brooks D; Halliday GM; Kril JJ, 2013, 'The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer's disease', Acta neuropathologica communications, 1, pp. 30, http://dx.doi.org/10.1186/2051-5960-1-30

Kim WS; Hsiao JT; Bhatia S; Glaros E; Don AS; Tsuruoka S; Shannon Weickert CS; Halliday GM, 2013, 'ABCA8 stimulates sphingomyelin production in oligodendrocytes', Biochemical Journal, 452, pp. 401 - 410, http://dx.doi.org/10.1042/BJ20121764

Abbott SK; Jenner AM; Mitchell T; Brown S; Halliday GM; Garner B, 2013, 'An Improved High-Throughput lipid extraction method for the analysis of human brain lipids', Lipids, 48, pp. 307 - 318, http://dx.doi.org/10.1007/s11745-013-3760-z

Kragh CL; Fillon G; Gysbers A; Hansen HD; Neumann M; Richter-Landsberg C; Haass C; Zalc B; Lubetzki C; Gai WP; Halliday GM; Kahle PJ; Jensen PH, 2013, 'FAS-Dependent Cell Death in á-Synuclein Transgenic Oligodendrocyte Models of Multiple System Atrophy', PLoS ONE, 8, pp. Article numbere 55243, http://dx.doi.org/10.1371/journal.pone.0055243

Dobson-Stone C; Luty A; Thompson EM; Blumbergs P; Brooks WS; Short CL; Field C; Panegyres P; Hecker J; Solski JA; Blair I; Fullerton JM; Halliday GM; Schofield PR; Kwok J; Schofield P, 2013, 'Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: Genetic, clinical and neuropathological analysis', ACTA Neuropathologica, 125, pp. 523 - 533, http://dx.doi.org/10.1007/s00401-013-1078-9

Davies KM; Hare DJ; Cottam V; Chen N; Hilgers L; Halliday GM; Mercer JFB; Double KL, 2013, 'Localization of copper and copper transporters in the human brain', Metallomics, 5, pp. 43 - 51, http://dx.doi.org/10.1039/c2mt20151h

Guerreiro PS; Huang Y; Gysbers A; Cheng D; Gai WP; Outeiro TF; Halliday GM, 2013, 'LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models', Journal of Molecular Medicine - Jmm, 91, pp. 513 - 522, http://dx.doi.org/10.1007/s00109-012-0984-y

Tan RH; Wong S; Hodges JR; Halliday GM; Hornberger M, 2013, 'Retrosplenial Cortex (BA 29) Volumes in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease', Dementia and Geriatric Cognitive Disorders, 35, pp. 177 - 182, http://dx.doi.org/10.1159/000346392

Reyes S; Fu Y; Double KL; Cottam V; Thomp LH; Kirik D; Paxinos G; Watson C; Cooper HM; Halliday GM, 2013, 'Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease', Neurobiology of Aging, 34, pp. 873 - 886, http://dx.doi.org/10.1016/j.neurobiolaging.2012.07.019

Thanos SM; Halliday GM; Damian DL, 2012, 'Nicotinamide reduces photodynamic therapy-induced immunosuppression in humans', BRITISH JOURNAL OF DERMATOLOGY, 167, pp. 631 - 636, http://dx.doi.org/10.1111/j.1365-2133.2012.11109.x

Sarchio SNE; Kok L-F; O'Sullivan C; Halliday GM; Byrne SN, 2012, 'Dermal mast cells affect the development of sunlight-induced skin tumours', EXPERIMENTAL DERMATOLOGY, 21, pp. 241 - 248, http://dx.doi.org/10.1111/j.1600-0625.2012.01438.x

Huang Y; Chegini F; Chua G; Murphy K; Gai W; Halliday GM, 2012, 'Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation', Translational Neurodegeneration, 1, http://dx.doi.org/10.1186/2047-9158-1-2

Fu Y; Yuan Y; Halliday GM; Rusznak Z; Watson C; Paxinos G, 2012, 'A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse', Brain Structure and Function, 217, pp. 591 - 612, http://dx.doi.org/10.1007/s00429-011-0349-2

Wong J; Higgins M; Halliday GM; Garner B, 2012, 'Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer's disease', Neuroscience, 210, pp. 363 - 374, http://dx.doi.org/10.1016/j.neuroscience.2012.02.037

Lewis SJG; Shine JM; Duffy S; Halliday GM; Naismith SL, 2012, 'Anterior cingulate integrity: Executive and neuropsychiatric features in Parkinson's disease', Movement Disorders, 27, pp. 1262 - 1267, http://dx.doi.org/10.1002/mds.25104

Back to profile page